Combination chemotherapy with paclitaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer

被引:0
作者
Yan-qin Lan
Ling-jun Kong
Xiao-yan Lin
Qian Xu
Xin-yan Gao
Ri-ping Wu
Xin-li Wang
Dong-ta Zhong
机构
[1] Fujian Medical University Union Hospital,Department of Medical Oncology
[2] Fujian Key Laboratory of Translational Cancer Medicine,Department of Thyroid and Breast Surgery
[3] Fujian Medical University Stem Cell Research Institute,undefined
[4] First Affiliated Hospital of Fujian Medical University,undefined
来源
Cancer Chemotherapy and Pharmacology | 2018年 / 81卷
关键词
Advanced gastric cancer; Paclitaxel; Oxaliplatin; Combination chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1007 / 1015
页数:8
相关论文
共 269 条
[1]  
Siegel R(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29
[2]  
Ma J(2010)Cancer trends in China Jpn J Clin Oncol 40 281-285
[3]  
Zou Z(2009)Cancer statistics, 2009 CA Cancer J Clin 59 225-249
[4]  
Jemal A(1997)Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer Ann Oncol 8 163-168
[5]  
Zhao P(2005)Comparison of cancer mortality (stomach cancer) in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960–2000) Jpn J Clin Oncol 35 103-105
[6]  
Dai M(2006)Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol 24 4991-4997
[7]  
Chen W(2008)Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36-46
[8]  
Li N(2008)S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215-221
[9]  
Jemal A(2003)Signal transduction pathways of taxanes-induced apoptosis Curr Med Chem Anticancer Agents 3 291-306
[10]  
Siegel R(1998)An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer Am J Clin Oncol 21 416-419